查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1138389

全球移植盒市场-2022-2029

Global Transplant Box Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

心血管疾病患病率上升导致市场增长。

根据世界卫生组织的数据，到 2021 年，每年将有 1790 万人死于心血管疾病。疾病控制和预防中心估计，全世界大约 32% 的死亡是由心血管疾病引起的。在美国，心脏病是人类死亡的第一大原因。在美国，每 34 秒就有一人死于心血管疾病。到 2020 年，美国约有 697,000 人将死于心脏病。冠心病是最常见的心脏病之一，2020年导致382,820人死亡。因此，不断升级的心血管疾病病例有望增加心臟移植的比例，从而推动移植盒市场的增长。此外，预计肝硬化等慢性肝病患病率的增加将推动预测期内的市场增长。

此外，政府还采取了鼓励器官捐赠的举措。政府加大力度促进器官捐赠也是预测期内推动移植盒市场的因素之一。根据 2020 年公布的全球器官捐赠和移植数据数据库，2020 年约有 129,681 个器官被移植。在这些器官移植中，肾移植 80,926 例，肝移植 32,586 例，心臟移植 8,101 例，肺移植 5,940 例，胰腺移植 1,970 例，S 肠移植 158 例。

此外，器官移植过程中的技术进步正在促进器官移植，促进市场增长。技术进步是有望加速移植盒市场增长的主要驱动因素。市场参与者不断努力推出技术先进的设备，以克服移植前器官存活时间短等挑战。例如，2020 年 3 月，荷兰生物技术公司 MIMETAS 宣布了 OrganoPlate，这是一种用于芯片上器官的检测就绪产品系列。它为开发器官模型提供了一个平台，例如肾臟、肝臟、血管、肠道和脑组织。

然而，由于器官移植成本高昂，寻求器官移植的患者数量明显减少，阻碍了市场增长。此外，器官供需失衡正在阻碍器官移植手术市场。此外，保险实践中器官移植的不确定报销方案也限制了预测期内对器官移植免疫抑製剂市场的需求。此外，器官移植的不确定报销方案也限制了预测期内移植盒市场的状况。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按应用划分的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
  • 驱动程序
    • 慢性病高发
    • 增加医疗保健支出
    • 增加有效治疗
  • 限制因素
    • 器官移植的高昂费用
  • 商机
  • 影响分析

第五章行业分析

  • 波特五力分析
  • 供应链分析
  • 价值链分析
  • PEST 分析
  • 定价分析
  • 监管分析
  • 保险报销分析
  • 未满足的需求
  • 专利趋势

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按应用程序

  • 心
  • 肝臟
  • 肺
  • 肾臟
  • 其他

第 8 章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 9 章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第 10 章公司简介

  • HIbernicor
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • OrganOx Limited
  • Institut Georges Lopez-IGL
  • Organ Recovery Systems, Inc.
  • Paragonix Technologies, Inc.
  • XVIVO Perfusion AB
  • Transmedics, Inc.
  • Other Companies

第11章 DataM

简介目录
Product Code: DMHCIT3039

Market Overview

Transplant Box Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 8.2 % during the forecast period (2022-2029).

Transplant box technology is an experimental organ transplant and preservation system. It lets the donor organ continue functioning outside the body while transporting it. The transplant box keeps the heart healthy and safe by protecting it in an environment similar to conditions inside the body, which includes the delivery of warmth and nourishment by blood and oxygen. The transplant box technology improves tissue matching between recipients and donors, as the box allows more time to test the organ for potential rejection factors. The package could help grow the donor pool by allowing the donor organ to be safely transported over longer distances. Rising cases of multiple organ failure across the globe, especially in developed economies, coupled with an increasingly geriatric population, are the major factors driving the transplant box market's growth.

Market Dynamics: The growing prevalence of cardiovascular disease leads to the market's growth.

According to World Health Organization data, 17.9 million people died annually from cardiovascular disease in 2021. The Centre for disease prevention estimated that around 32% of deaths worldwide are due to cardiovascular disease. In the United States, heart disease is the leading cause of human death. One person dies every 34 seconds in the United States from cardiovascular disease. About 697,000 people in the United States died from heart disease in 2020. Coronary heart disease is one of the most common types of heart disease, killing 382,820 people in 2020. Thus, escalating cardiovascular disease cases are anticipated to raise the rate of heart transplants, thereby propelling the growth of the transplant box market. Furthermore, the increasing prevalence rate of chronic liver ailments such as liver cirrhosis is expected to boost market growth over the forecast period.

Moreover, Government initiatives to encourage organ donation. The rise in government initiatives to promote organ donation is another factor anticipated to propel the transplant box market during the forecast period. According to the global database on donation and transplantation data published in 2020, around 129681 organs were transplanted in the year 2020. Among these organ transplants, 80,926 are kidney transplants, 32,586 are liver transplants, 8,101 are heart transplants, 5,940 are lung transplants, and 1,970 are pancreas transplants and 158 S. Bowel transplants.

In addition, technological advancement in the organ transplant process drives organ transplants, thereby aiding the market's growth. Technological advancements are a major driver expected to accelerate the growth of the transplant box market. Market players always strive to introduce technologically advanced devices to overcome challenges, including the short duration of organ survival before transplantation. For instance, in March 2020, a Dutch biotech company, MIMETAS, introduced assay ready product line for organ-on-a-chip, OrganoPlate. It provides a platform for developing organ models, such as kidneys, liver, blood vessels, gut, and brain tissues.

However, the high cost associated with organ transplantations significantly reduces the number of patients opting for the design, thereby hampering the market's growth. Additionally, the disproportion in the supply and demand for organs hampering the organ transplant procedures market. Moreover, the uncertain reimbursement scenario of organ transplants in the insurance process also restricts the need for organ transplant immunosuppressant drugs market during the forecast period. Moreover, organ transplants' uncertain reimbursement scenario also limits the condition of the transplant box market during the forecast period.

Market Segmentation: Kidney segment accounted for the highest share in transplant box market.

The kidney segment is anticipated to experience a significant growth rate in the transplant box market. For instance, According to Organ Donation Statistics, in 2020, there were 80,926 kidney transplants done which was 31.70% of total transplants done globally. There 55258 kidney transplants were done from deceased donors, and 25668 kidney transplants were done from living donors. Kidney transplantation or dialysis is the only treatment option to keep a patient alive. Thus, the demand for transplant boxes is expected to surge shortly. Therefore, the need for transplant boxes in kidney transplantation is estimated to contribute interestingly to the market's growth across the globe.

Geographical Penetration: North America is the dominating region during the forecast period.

The North American market leads with the largest market share in the global transplant box market during the forecast period. A technologically advanced healthcare infrastructure drives the growth in the U.S. This, in turn, has led to a rise in the number of transplants, thereby boosting the market share in the region. Moreover, the high investment in advanced technologies in the US healthcare sector is further expected to escalate the region's market growth during the forecast period.

Furthermore, the Asia Pacific region is expected to grow at the highest CAGR globally, owing to a considerable rise in healthcare spending to establish developed healthcare infrastructure in the area. The rising geriatric population and the increase in medical tourism due to the low cost of surgical procedures contribute to the growth of the area's market. The increase in the number of chronic diseases in the area is further contributing to the development of the transplant box market in the area.

Competitive Landscape:

The transplant box market is dominated by a few companies. Some key players in the market's growth include HIbernicor, Organix Limited, Institut Georges Lopez-IGL, Organ Recovery Systems, Inc., Paragonix Technologies, Inc., XVIVO Perfusion AB, Transmedics, Inc., and TeamBest, among others. The key players execute several growth strategies, such as product launches, acquisitions, and collaborations, which are estimated to boost the transplant box market growth globally. For instance, in March 2020, Paragonix Technologies, Inc. announced that AdventHealth, a non-profit healthcare service provider in Florida, had given the nod for using its Paragonix SherpaPak CTS to preserve donors' hearts meant for transplantation. In May 2022, OrganOx, a world leader in normothermic machine perfusion (NMP), announced a partnership with Ochre Bio for chronic liver diseases. In December 2021, OrganOx announced that it got FDA approval for its metra normothermic machine perfusion (NMP) system. This device is mostly used to preserve and transport donor livers set for transplantation. The transportable device sustains donor livers in a functioning state for up to 12 hours, mimicking the environment of the human body with warm, oxygenated blood and nutrients between donation and transplantation. In August 2021, Paragonix Technologies Announced the Launch of the New OPTION On-Demand Preservation Services Network in the United States. Due to increased product demands and the need for quick service, Paragonix launched this just-in-time service to ensure the 24/7 availability of Paragonix organ preservation products.

COVID-19 Impact: Positive impact on the transplant box market.

The transplant box depends on the number of new heart diseases, lung diseases, and others. The COVID-19 pandemic has negatively impacted the growth of the market due to the decline in the number of diagnostic procedures, which has decreased the number of new cases of diseases and, ultimately, the demand for transplant boxes across the globe. Moreover, people have avoided hospital visits to contain COVID-19. Furthermore, the deviation in the development of the COVID-19 vaccine in the research institutes and pharmaceutical companies and the R&D in technologically advanced transplant boxes declined in 2020. Therefore, the transplant box market will witness a downfall in market revenue in 2020 and subsequent years.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Application
  • 3.2. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. The high incidence rate of chronic diseases
    • 4.2.2. Improved spending on healthcare
    • 4.2.3. The rise in the availability of effective treatment methods
  • 4.3. Restraints:
    • 4.3.1. The high cost of organ transplant procedures
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 7.1.2. Market Attractiveness Index, By Application Segment
  • 7.2. Heart
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 7.3. Liver
  • 7.4. Lung
  • 7.5. Kidney
  • 7.6. Others

8. By Region

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 8.3. Market Attractiveness Index, By Region
  • 8.4. North America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.4.1. The U.S.
      • 8.4.4.2. Canada
      • 8.4.4.3. Mexico
  • 8.5. Europe
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.4.1. Germany
      • 8.5.4.2. The U.K.
      • 8.5.4.3. France
      • 8.5.4.4. Italy
      • 8.5.4.5. Spain
      • 8.5.4.6. Rest of Europe
  • 8.6. South America
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.6.4.1. Brazil
      • 8.6.4.2. Argentina
      • 8.6.4.3. Rest of South America
  • 8.7. Asia Pacific
    • 8.7.1. Introduction
    • 8.7.2. Key Region-Specific Dynamics
    • 8.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.7.4.1. China
      • 8.7.4.2. India
      • 8.7.4.3. Japan
      • 8.7.4.4. Australia
      • 8.7.4.5. Rest of Asia Pacific
  • 8.8. The Middle East and Africa
    • 8.8.1. Introduction
    • 8.8.2. Key Region-Specific Dynamics
    • 8.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

  • 10.1. HIbernicor*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Key Highlights
    • 10.1.4. Financial Overview
  • 10.2. OrganOx Limited
  • 10.3. Institut Georges Lopez-IGL
  • 10.4. Organ Recovery Systems, Inc.
  • 10.5. Paragonix Technologies, Inc.
  • 10.6. XVIVO Perfusion AB
  • 10.7. Transmedics, Inc.
  • 10.8. Other Companies

11. DataM Intelligence

  • 11.1. Appendix
  • 11.2. About Us and Services
  • 11.3. Contact Us